nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Comprehensive Analysis of Clinical Logistic and Machine Learning-Based Models for the Evaluation of Pulmonary Nodules
|
Zhang, Kai |
|
|
3 |
4 |
p. |
artikel |
2 |
Heterogeneous Outcomes of Immune Checkpoint Inhibitor Rechallenge in Patients With NSCLC: A Systematic Review and Meta-Analysis
|
Xu, Shiting |
|
|
3 |
4 |
p. |
artikel |
3 |
Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ): Measurement Properties and Estimated Clinically Meaningful Thresholds From a Phase 3 Study
|
Williams, Paul |
|
|
3 |
4 |
p. |
artikel |
4 |
Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC—Results From a Prospective Pilot Study
|
Thompson, Jeffrey C. |
|
|
3 |
4 |
p. |
artikel |
5 |
Relationship Between Pathologic T1 Categories and Pathologic Factors Affecting Prognosis in Pulmonary Adenocarcinoma
|
Ninomiya, Hironori |
|
|
3 |
4 |
p. |
artikel |
6 |
RELAY+: Exploratory Study of Ramucirumab Plus Gefitinib in Untreated Patients With EGFR-Mutated Metastatic NSCLC
|
Nishio, Makoto |
|
|
3 |
4 |
p. |
artikel |
7 |
Sex Differences in Lung Cancer Treatment and Outcomes at a Large Hybrid Academic-Community Practice
|
Stabellini, Nickolas |
|
|
3 |
4 |
p. |
artikel |
8 |
Stigma May Exacerbate Disproportionately Low Guideline-Concordant Treatment Rates for Patients With Advanced-Stage Lung Cancer in the United States
|
Peng, Terrance |
|
|
3 |
4 |
p. |
artikel |
9 |
The Role of Real-World Evidence to Support Treatment Choices in Malignant Pleural Mesothelioma
|
Wheatley-Price, Paul |
|
|
3 |
4 |
p. |
artikel |
10 |
Trends of Molecular Testing for Lung Cancer at the King Faisal Hospital, Kigali: Therapeutic and Survival Implications
|
Van Christ Manirakiza, Achille |
|
|
3 |
4 |
p. |
artikel |